Monovoukas: * of *

CHRISTOS MONOVOUKAS

ad2g47@r.postjobfree.com www.linkedin.com/in/christosmonovoukas 978-***-**** EXECUTIVE SUMMARY

Highly collaborative, influential, and accomplished Healthcare Senior Executive with demonstrated ability to drive company growth tightly aligned with corporate strategy. Leadership experience spans all functional areas including M&A, venture investing, business development, corporate strategy, and operations. Harvard MBA, Columbia University MS Mechanical Engineering. EXPERTISE

Corporate Development / M&A / Ventures Technology Commercialization P&L / Operations Management Strategy Development / Execution Product Development / Launch Startup / Turnaround / Growth New Market Development / Expansion FDA / CE Mark / GMP Regulations Leadership / Staff Development SELECT LEADERSHIP CONTRIBUTIONS

Led Zimmer Biomet’s Global Business Group’s M&A. Closed 5 deals in one year (Embody, Tightline, Avitus, Medstrat, and VIMS). Proposed and got approval for a Corporate Venture Fund, a new growth initiative for Zimmer Biomet.

Developed and drove Olympus America’s 5-year strategic planning process ($2 billion business with 6 separate Business Units).

Led strategic acquisitions that transformed Olympus Corporation (Quest Photonic, Veran, FH Ortho, ARC, Image Stream).

Built and led Olympus Innovation Ventures, a $50 million corporate venture fund.

Key role in providing equity investment to Medi-Tate in a structured deal (Israeli startup company in urology market).

Key role in acquiring Healthpoint Biotherapeutics for $782 million (Smith & Nephew’s largest acquisition at the time, 2012).

Built annual revenue from $12 million to $50 million in less than 2 years. Sold company to Thoratec for $150 million.

Key role in growing business from startup to $5 million annual run rate. Sold company to Corning, Inc. for $750 million.

Past board member of MassMedic (Largest regional MedTech association in the US). PROFESSIONAL EXPERIENCE

ZIMMER BIOMET, Inc. Warsaw, IN (NASDAQ: ZBH) 11/2022 – Present Vice President, Business Development and Ventures

Recruited to serve as the leader for business development and strategy in partnership with Global Business Unit leaders for Zimmer Biomet, a multibillion dollar orthopeadics company.

Leading team of Investment Professionals on all business development transactions including acquisitions, VC/minority investments, divestitures, licensing deals, co-development agreements and joint ventures in support of company strategies.

Developing inorganic growth plans in collaboration with Global Business Unit, R&D and other internal stakeholders.

Responsible for establishing a corporate venture capital program, working directly with ZB executive leadership to define the investment mandate, structure, processes, and governance to ensure they meet their strategic and financial objectives. EVOLUS, Inc. Newport Beach, CA (NASDAQ: EOLS) 03/2022 – 11/2022 Senior Vice President, Corporate Development

Evolus is a medical aesthetics and beauty company with a customer-centric approach to delivering breakthrough products in the self- pay aesthetic market. The company's first commercial product, Jeuveau, is a proprietary purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines.

Recruited to drive Corporate Development and Strategy.

Developed M&A roadmap in collaboration with CEO. Monovoukas: 2 of 3

OLYMPUS Corporation of the Americas, Southborough, MA 08/2014 – 03/2022 Vice President, Global M&A Lead / Business Development, 06/2019 – 03/2022 Promoted to lead Olympus' Global Corporate Development function with focus on M&A. Coordinating the identification, assessment and execution of business development transactions including acquisitions, VC/minority investments, divestitures, licensing deals, co-development agreements and joint ventures in support of company strategies and goals. Work with Division, Business Unit, R&D and other internal stakeholders to develop inorganic growth plans. Establish standard tools, models, and systems to make the M&A and venture investment processes clear, systematic, and efficient. Directing the work of Investment Professionals in US, EU & APAC. Corporate Development:

Negotiated and closed M&A transactions: Veran Technologies, ARC Medical, FH Ortho and Image Stream Medical.

Closed equity investment in Medi-Tate (observer board seat) and Surgigyn (UVM spin out).

Started and led Olympus corporate venture capital group (Olympus Innovation Ventures) with $50m. Established Technology Scouting team in Bay Area.

Act as “Olympus embassador” within the Investment Banking, private equity, venture capital and business development communities. Represent Olympus within industry groups (member of ADVAMED’s Business Development team) and speaking at industry events (judge at MedTech Innovator’s annual business competition, moderator to roundtable discussions). Strategic Planning:

Work closely with the COO and Global Business Unit Presidents and GMs on strategy development.

Collaborated with Strategic Global Business Unit leaders to develop business strategies such as market development strategies, go-to-market plans, service models, selling methodologies, alternate approaches to positioning, geographic opportunities, etc.

Led annual strategic planning process of Olympus America.

Diligenced potential business opportunities to determine fit with overall corporate strategy. Work with founding teams of startup companies to develop business cases and investment options. Vice President of Business Development and Strategy, 08/2014 – 06/2019 Recruited to build Olympus’ Business Development and Strategy function. Analyzed markets to identify strategic growth opportunities for Olympus. Led the company’s annual strategic planning process. Managed a team of three BD professionals.

Recruited team of BD professionals. Designed, developed and operationalized a M&A process.

Architected and drove the strategic business planning process for GI, Gyn/Uro, ENT, and Surgical Endoscopy Business Units. SMITH & NEPHEW, INC., Andover, MA 2010 – 5/2014

Vice President, Strategic New Business Development Responsible for planning and executing S&N divisions growth strategies (Advanced Woundcare Management Division, Sports Med Division, Orthopedics Division). Led cross-functional due diligence teams on new business development opportunities.

Performed due diligence on 21 M&A targets. Closed 4 deals: o Healthpoint Biotherapeutics (2012), Lifemodeler (2012), Kalypto (2012), Arthrocare (2014)

Coordinated In-Ventures process with Research & Technology innovation team to identify and evaluate offered technology and ideations, early-stage business development, and licensing deals.

Defined immediate and long-term strategy and secured funding to develop new business opportunities such as Animal Health. o Built and expanded the Animal Health vertical market within Smith & Nephew. o Grew annual revenue of Animal Health franchise from less than $500K to $1.5 million within 12 months.

Managed New Market Development Team comprised of 2 Directors and a Senior Manager. Gathered commercial, clinical, and customer insights to assess appropriate market opportunities and drive innovation. Key role in growth of global AWM division from $800 million to $1.2 billion through acquisition and organic channels.

Defined strategy and business plan for launch of new product category and strategic business unit (Pressure Ulcer Prevention) with projected revenue potential of $100 million in 5 years.

Developed business plans/cases and built financial models to assess market opportunities and potential technology investments as a basis for go/no-go strategic decisions.

Led 22-member team in successful pilot for product launch at 9 clinical sites in the US and UK.

Developed approach, gained alignment and led Division-wide strategic planning process. Synthesized information from multiple sources to generate insights and recommendations on long-range strategies. Monovoukas: 3 of 3

PHAROS, LLC, Waltham, MA 2004 – 2010

Vice President, New Business Development

Recruited to join this private investment, MedTech incubator and participated in management of $100 million fund.

Evaluated and recommended investment opportunities. Made investments $500 - $1 million.

Assigned to run US operations of Levitronix, a Pharos portfolio company developing a LVAD device. o With Levitronix CEO, developed outsourcing strategy to set up manufacturing in China; sourced/selected vendors and established China operations; reduced component manufacturing costs 10-fold. o Managed business expansion; opened Customer Support office in Japan; improving client response time 85%. o Grew sales from $12 million to $50 million. Levitronix Medical was sold to Thoratec for $150 million in 2011. o Improved gross margins from 40% to 75% by identifying and resolving manufacturing issues.

Incubated viscometer product idea based on magnetic levitation technology. Incorporated Levimetrix, LLC to commercialize system for the blood testing market (PT/INR testing). CORNING INTELLISENSE, Wilmington, MA (Corning, Inc. subsidiary following acquisition of IntelliSense) 1999 – 2004 General Manager, 2001 - 2004

Retained following acquisition to run the operations of a Micro-Electro-Mechanical Systems (MEMS) foundry business unit.

Increased revenue 20% and improved gross margin 8%, despite MEMS market downturn.

Defined and executed strategy to offset acquisition costs via new vertical markets including medical device and life sciences; won contracts with Advion BioSciences, Alcon Laboratories, General Electric Healthcare and others; negotiated and won 21 product development/manufacturing contracts totaling $6+ million.

Directed development of products in drug delivery/discovery, mass spectrometry, gas chromatography and microfluidics.

Presented at MEMS conference in Japan and soon after launched sales channel in Japan, an emerging MEMS market; trained local representatives on proprietary software used in the design and development of MEMS.

Oversaw the construction of new, 12,000 s.f. cleanroom which tripled manufacturing capacity. Obtained ISO 9001 registration.

Key member of M&A team that identified, evaluated, and conducted due diligence on acquisition targets. Director of Business Development - IntelliSense Corp., 1999-2001

Recruited by CEO to join IntelliSense Corp. during the early stage of the company.

Managed product development projects primarily funded by the US government; designed and built products including Biosensor, Gyroscope, and DNA Micro-array for OEMs.

With the founder, developed and implemented strategy to pursue corporate accounts. Began selling design and prototype capability to companies like General Electric, Agilent Technologies, Alcon Labs, and Corning, Inc.

Grew to $5 million annual run rate; key role in negotiating the sale of the company to Corning, Inc. for $750 million. VITAL INSITE, INC., San Francisco, CA 1997 – 1998

Product Development Manager, Electromechanical Group

Recruited to venture-backed medical device startup developing a unique, non-invasive and continuous, blood pressure monitoring device (Dr. Tom Fogarty’s portfolio company). Led feasibility study of 1st-generation device on 30 volunteer patients at Stanford Hospital.

RAYCHEM CORPORATION, MENLO PARK, CA 1994 – 1997

Senior Manufacturing Engineer, PolySwitch Division

Hired to the newly created position of Manager of the Design & Modeling Group; managed team of 2 Senior Engineers.

Designed/developed manufacturing machine (the “snapper”) which enabled Raychem to mass produce a low-cost, miniature fuse product; negotiated $1 million contract and commissioned building of the machine; product has generated $100+ million to date. MOORE BUSINESS FORMS, INC., Grand Island, NY 1988 – 1994 Senior Mechanical Engineer, R&D, Moore Research Center

Key contributor to 300-member R&D group that developed new printing technologies for Moore's global business sectors.

Designed toner and toner development system to make checks tamperproof/photocopy proof. Patent filed on the technology. EDUCATION

MBA, General Management, Harvard University Business School Boston, MA, June 1999 Internship, MS, Mechanical McKinsey Engineering, & Company, June Inc.1988,, Summer Columbia 1998 University Member, Small New York, Business NY & Entrepreneurship Club Co-president, Sailing Club Awarded Graduate Teaching Assistantship

BS, Mechanical Engineering, Columbia University New York, NY, June 1987 Recipient of 4-year Fulbright Scholarship based on academic excellence

Contact this candidate